PDLIM2 acts as a central regulator of ubiquitination, immune signaling, and mitochondrial metabolism in lung cancer suppression (Review).

Saved in:
Bibliographic Details
Title: PDLIM2 acts as a central regulator of ubiquitination, immune signaling, and mitochondrial metabolism in lung cancer suppression (Review).
Authors: Chuang TH; Cardiovascular and Mitochondrial Related Disease Research Center, Hualien Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Hualien 970473, Taiwan, R.O.C., Guo JH; Department of Neurosurgery, China Medical University Hospital, Taichung 404327, Taiwan, R.O.C., Yang JX; Jim and Eleanor Randall Department of Surgery, Cedars‑Sinai Medical Center, Los Angeles, CA 90048, USA., Tseng JC; Immunology Research Center, National Health Research Institutes, Miaoli 350401, Taiwan, R.O.C., Wang HJ; Institute of Medical Sciences, Tzu Chi University, Hualien 970374, Taiwan, R.O.C., Lai CY; Department of Medical Laboratory Science and Biotechnology, Asia University, Taichung 41354, Taiwan, R.O.C.
Source: International journal of oncology [Int J Oncol] 2026 Aug; Vol. 69 (2). Date of Electronic Publication: 2026 Jul 03.
Publication Type: Journal Article; Review
Journal Info: Publisher: D.A. Spandidos Country of Publication: Greece NLM ID: 9306042 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1791-2423 (Electronic) Linking ISSN: 10196439 NLM ISO Abbreviation: Int J Oncol Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1791-2423
DOI:10.3892/ijo.2026.5909